Eastern Bank’s Artiva Biotherapeutics ARTV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.1K Buy
+155
New +$1.56K ﹤0.01% 1060

Other funds holding ARTV

Eastern Bank's ARTV Position: Q3 2026 in Review

Eastern Bank opened a new position in Artiva Biotherapeutics (ARTV) in Q3 2026: 155 shares worth $1.1K. The stake represents ﹤0.01% of the portfolio and ranks #1060 among its holdings.

3 funds tracked by Wall St. Rank hold ARTV as of Q3 2026.

  • Eastern Bank held 155 shares of Artiva Biotherapeutics worth $1.1K as of Q3 2026.
  • Artiva Biotherapeutics was a new Eastern Bank position in Q3 2026.
  • Artiva Biotherapeutics made up ﹤0.01% of Eastern Bank's portfolio in Q3 2026, its #1060 holding.
  • 3 funds tracked by Wall St. Rank held Artiva Biotherapeutics as of Q3 2026.

Based on Eastern Bank's 13F filing for Q3 2026, filed 5 Oct 2026.